Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on BioCryst (BCRX – Research Report) today. The company’s shares opened today at $7.62. Ahmad covers the Healthcare sector, ...

These unexpected attacks can also close off airways, potentially becoming fatal. Few treatments are available for this rare disorder but BioCryst Pharmaceuticals can now offer HAE patients another one ...

Pharmaceuticals announced that the compensation committee of BioCryst’s board of directors granted five newly-hired ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

View BioCryst Pharmaceuticals, Inc. (BCRX) current and estimated P/E ratio data provided by Seeking Alpha.

JP Morgan has recently resumed BioCryst Pharmaceuticals Inc (BCRX) stock to Overweight rating, as announced on November 20, 2023, according to Finviz. Earlier, on September 18, 2023, RBC Capital Mkts ...

A rumor that food company Land O'Lakes had announced a return to its previous logo featuring a kneeling Indigenous woman on its packaging circulated online in October 2024. A Facebook post ...

JP Morgan has recently resumed BioCryst Pharmaceuticals Inc (BCRX) stock to Overweight rating, as announced on November 20, 2023, according to Finviz. Earlier, on September 18, 2023, RBC Capital Mkts ...

Explore the YouTube logo design, uncover psychology, and learn tips for creating unforgettable logos. Elevate your brand with expert insights. Have you ever caught yourself mindlessly scrolling ...

RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2024 financial results ...